Antimicrobial Effect of Asiatic Acid Against Clostridium difficile Is Associated With Disruption of Membrane Permeability

被引:23
|
作者
Harnvoravongchai, Phurt [1 ]
Chankhamhaengdecha, Surang [1 ]
Ounjai, Puey [1 ]
Singhakaew, Sombat [1 ]
Boonthaworn, Kanpong [1 ]
Janvilisri, Tavan [2 ]
机构
[1] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand
[2] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand
来源
关键词
Clostridium difficile; asiatic acid; antimicrobials; drug resistance; herb; CANCER CELLS; IN-VITRO; RESISTANCE; INFECTION; METRONIDAZOLE; SPORES; SUSCEPTIBILITY; EPIDEMIOLOGY; TRANSMISSION; INACTIVATION;
D O I
10.3389/fmicb.2018.02125
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antibiotic resistance is a major concern in Clostridium difficile, the causative agent of antibiotic-associated diarrhea. Reduced susceptibility to first-and second-line agents is widespread, therefore various attempts have been made to seek alternative preventive and therapeutic strategies against this pathogen. In this work, the antimicrobial properties of asiatic acid were evaluated against C. difficile. Asiatic acid displayed substantial inhibitory effects on 19 C. difficile isolates collected from different sources with minimal inhibitory concentrations ranging from 10 to 20 mu g/ml. Time kill analysis and minimal bactericidal concentration revealed potential bactericidal activity of this compound. Asiatic acid induced membrane damages and alterations in morphological ultrastructure in C. difficile, thereby causing the leakage of intracellular substances. Moreover, asiatic acid also displayed an inhibitory effect on cell motility, but did not interfere with biofilm formation and spore germination. Analysis of drug combination showed no synergistic effect between asiatic acid and vancomycin/metronidazole. Altogether, asiatic acid exhibited strong antimicrobial activity against vegetative cells and could serve as an alternative resource for tackling C. difficile.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Antifungal effect of chlorogenic acid against pathogenic fungi with membrane-disruption effect
    Lee, Dong Gun
    Sung, Woo Sang
    JOURNAL OF BIOTECHNOLOGY, 2008, 136 : S75 - S75
  • [22] Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile
    Odenholt, Inga
    Walder, Mats
    Wullt, Marlene
    CHEMOTHERAPY, 2007, 53 (04) : 267 - 274
  • [23] In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait
    Jamal, WY
    Mokaddas, EM
    Verghese, TL
    Rotimi, VO
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (04) : 270 - 274
  • [24] Antimicrobial activity of fidaxomicin against Clostridium difficile clinical isolates in Aichi area in Japan
    Yamagishi, Yuka
    Nishiyama, Naoya
    Koizumi, Yusuke
    Matsukawa, Yoko
    Suematsu, Hiroyuki
    Hagihara, Mao
    Katsumata, Kiyomitsu
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (10) : 724 - 726
  • [25] LETTER: Collagenous Colitis Associated with Clostridium difficile: A Cause Effect?
    Tolga Erim
    Waleed M. Alazmi
    Colm J. O'Loughlin
    Jamie S. Barkin
    Digestive Diseases and Sciences, 2003, 48 : 1374 - 1375
  • [26] Antimicrobial Activity of Tannic Acid In Vitro and Its Protective Effect on Mice against Clostridioides difficile
    Wang, Weigang
    Cao, Jing
    Yang, Jing
    Niu, Xiaoran
    Liu, Xiaoxuan
    Zhai, Yu
    Qiang, Cuixin
    Niu, Yanan
    Li, Zhirong
    Dong, Ning
    Wen, Baojiang
    Ouyang, Zirou
    Zhang, Yulian
    Li, Jiayiren
    Zhao, Min
    Zhao, Jianhong
    MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [27] Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile
    Noren, T.
    Akerlund, T.
    Wullt, M.
    Burman, L. G.
    Unemo, M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (05) : 1840 - 1843
  • [28] Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK
    Delaney, J. A. Chris
    Dial, Sandra
    Barkun, Alan
    Suissa, Samy
    EMERGING INFECTIOUS DISEASES, 2007, 13 (05) : 761 - 763
  • [29] Role of Antimicrobial Stewardship Programs in Decreasing Hospital-Associated Clostridium difficile Infections
    Aljefri, Doaa M.
    Christensen, Alyssa B.
    Gibson, Amanda K.
    Postelnick, Michael
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2018, 10 (02) : 270 - 280
  • [30] Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea:: This is an antimicrobial resistance problem
    Gerding, DN
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) : 646 - 648